Thus, thiscollaborative investigation carried out by two independent teams of researchers attwo different sites on different ethnic patient populations provides strong evidencethat miR-141 is a valid plasma marker that complements CEA in determining stage IVcolon cancer. The gene discussed is CEACAM5; the disease is cancer.